Pulsed dosing and extended daily dosing of oral vancomycin do not facilitate clearance of Clostridioides difficile colonization in mice
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.00903-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Basya S Pearlmutter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Service, Louis Stokes Cleveland VA Medical Center , Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
Vancomycin taper and pulse regimens are commonly used to treat recurrent Clostridioides difficile infections, but the mechanism by which these regimens might reduce recurrences is unclear. Here, we used a mouse model to test the hypothesis that pulse dosing of vancomycin after a 10-day treatment course enhances clearance of C. difficile from the intestinal tract. Mice with C. difficile colonization received 10 days of once-daily oral vancomycin followed by 20 days of treatment with saline (controls), daily vancomycin, or pulse dosing of vancomycin every 2 or 3 days. Stool samples were collected to measure the concentration of C. difficile during and after treatment, vancomycin concentrations, and growth of vegetative C. difficile during every 3 days dosing. Pulse dosing of vancomycin was not effective in maintaining suppression of C. difficile ( P > 0.05 in comparison to saline controls); growth of vegetative C. difficile occurred between pulse doses when vancomycin decreased to undetectable levels. Daily dosing of vancomycin suppressed C. difficile during treatment, but recurrent colonization occurred after treatment in more than 75% of mice, and by post-treatment day 14, there was no significant difference among the control, pulse dosing, and daily dosing groups ( P > 0.05). These findings demonstrate that pulse dosing of vancomycin every 2 or 3 days does not facilitate the clearance of C. difficile spores in mice. Studies are needed to examine the impact of vancomycin taper and pulsed regimens in patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Service, Louis Stokes Cleveland VA Medical Center , Cleveland, Ohio, USA.
- Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center , Cleveland, Ohio, USA.
- Case Western Reserve University School of Medicine , Cleveland, Ohio, USA.
- Lerner Research Institute/Lerner College of Medicine of Case Western Reserve University , Cleveland, Ohio, USA.
ORCID-Profile: Curtis J Donskey
Förderung
- CSRD VA
- U.S. Department of Veterans Affairs
Zitieren
APA
Pearlmutter, B. S., Carlisle, M. G., Wilson, B. M., Sangwan, N., & Donskey, C. J. (2024). Pulsed dosing and extended daily dosing of oral vancomycin do not facilitate clearance of Clostridioides difficile colonization in mice. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00903-23
Vancouver
Pearlmutter BS, Carlisle MG, Wilson BM, Sangwan N, Donskey CJ. Pulsed dosing and extended daily dosing of oral vancomycin do not facilitate clearance of Clostridioides difficile colonization in mice. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00903-23
BibTeX
@article{Pearlmutter2024,
author = {Pearlmutter, Basya S and Carlisle, Matthew G and Wilson, Brigid M and Sangwan, Naseer and Donskey, Curtis J},
title = {Pulsed dosing and extended daily dosing of oral vancomycin do not facilitate clearance of Clostridioides difficile colonization in mice},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.00903-23}
}
EUVIMED